Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)
Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients…
FAIR PLAY MENARINI: THE NAMES OF THE PARTICIPANTS AT ‘THE CHAMPIONS TELL THEIR STORIES’ TALK SHOW ARE REVEALED
FLORENCE, Italy, Nov. 20, 2024 /PRNewswire/ -- The journey of the 28th Fair…
FAIR PLAY MENARINI: THE NAMES OF THE PARTICIPANTS AT ‘THE CHAMPIONS TELL THEIR STORIES’ TALK SHOW ARE REVEALED
FLORENCE, Italy, Nov. 20, 2024 /PRNewswire/ -- The journey of the 28th Fair…
